| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.095 | 0.07 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |